The experts’ point of view: check out the main analysis on the Life Sciences sector

What do you need to know about the Life Sciences sector to stay ahead in the market? To provide a complete overview of the sector, the review The experts’ point of view: Life Sciences brings analyses and insights on the regulatory, transactional and tax fronts.

In the cover story, partners Rubens Granja and Maira Materagia Imperatriz, from the Life Sciences & Healthcare practice, Ana Carolina Utimati, from the Tax practice and Laura Affonso, from the Corporate and M&A practice, analyze the opportunities for partnerships in the health sector in 2024, based on the new business models and partnerships emerging from the Health PAC, as well as companies seeking synergies through major acquisitions in the sector.

In a full interview with our experts, we present the current scenario in the sector, outlining the business landscape, the highlights of the regulatory agenda and the potential loopholes for disputes in the sector. Check it out the main topics discussed in the interview with our partners:

• Opportunities for the health sector and prospects for new investments and M&As;
• Health PAC updates;
• Main innovations and effects of Law 14.874/2024 on clinical research with human subjects;
• Impacts of RDC 786/2023 on the market: clinical analysis tests in pharmacies;
• Points of attention that can lead to litigation in the sector;
• Scenario on the ANS list of procedures;
• Product pricing;
• Highlights of the regulatory agenda for the coming years.

Finally, the review brings a business barometer, where you’ll find the main opportunities and points of attention in the Life Sciences sector so you can prepare for what is to come.

To prepare for the industry’s upcoming challenges, check out the full material.